New to GLP-1s? Start with whether it's right for you ->
Verify GLP-1 vial volume short fill: the short answer
To verify your GLP-1 vial volume, check the labeled volume on the vial, draw and measure what is actually inside in syringe units, and count it against the number of full doses you should get at your prescribed dose - if the math comes up short, you likely have a short-fill. This is a real failure mode: one r/pomhealth buyer reported a tirzepatide vial labeled 3mL that held only about 1.9mL, ran empty after two doses, and got told she 'must have been mistaken.' The structural protection against it is sourcing from a provider whose 503A compounding pharmacy is publicly named and supplies a certificate of analysis (COA) per lot - which is exactly the product-quality-verification axis our framework weights at 1.5x. The four-step verification below catches a short-fill after the fact; naming the pharmacy and demanding a COA prevents most of them up front.
The scorecard
Each axis is scored 1 to 5 the way a physician would evaluate where to send a patient. Patient-safety screening and product-quality verification carry 1.5× weight because they are the load-bearing safety signals. Axes we have not yet verified say so - we never invent a number.
| Axis | Weight | Sesame Care |
|---|---|---|
| Patient-safety screening | 1.5× | Pending verification |
| Product-quality verification | 1.5× | Pending verification |
| Informed consent and transparency | 1× | 4 / 5 |
| Prescriber model | 1× | 5 / 5 |
| Continuity of care | 1× | Pending verification |
| Conflict of interest disclosure | 1× | 4 / 5 |
| Pricing transparency and ethics | 1× | 5 / 5 |
| State coverage | 1× | Pending verification |
| Independent reputation | 1× | Pending verification |
| Specialization vs shotgun | 1× | 3 / 5 |
| Weighted composite | / 50 | 34.5 / 50 Tier B (provisional) |
Live from our 10-axis doctor-ethical framework. Source data: /data/partner-scorecard.json. “Pending verification” means we hold the affiliate relationship but have not finished that axis - default to a fully scored partner until it publishes.
The audit log (proof the framework is real)
The scorecard moves both directions. We dropped our own former #1 pick on an FDA letter and publicly corrected an over-extension within 24 hours. That is the difference between a framework and a commission funnel.
2026-05-30 · Promoted · Sesame Care
We point short-fill-burned readers to a doctor-first marketplace where the booked provider's dispensing pharmacy can be identified and a COA requested, rather than to an opaque funnel that will not name who actually compounds the product. Product-quality verification carries 1.5x weight in our framework precisely because of failure modes like the Pom Health short-fill - a named 503A pharmacy with a COA per lot is the floor.
Full reasoning and every prior cycle is published at how we evaluate partners.
How to verify your GLP-1 vial volume
- Read the labeled volume and concentration. Find the labeled total volume (for example 3mL) and the concentration (for example 10mg/mL) printed on the vial. Multiply them to get the total milligrams you paid for. Keep the label and the packing slip - you will need them if you have to escalate.
- Draw and measure what is actually in the vial. With a fresh syringe, draw the full contents of the vial and read the volume in syringe units against the markings. Do this before your first dose if you can. A vial labeled 3mL should draw close to 3mL, allowing for a small amount of unavoidable residual in the stopper.
- Count your real doses against the expected doses. Divide the measured volume by your per-dose volume to get how many doses the vial actually contains, then compare to what your prescription says it should yield. If a vial that should give you eight doses is empty after four or five, the volume was short - the dose was not the problem.
- Document the gap and escalate in writing. Photograph the label, the filled syringe against its markings, and the empty vial. Report the discrepancy to the provider and the dispensing pharmacy in writing, reference the labeled-versus-measured volume, and request a replacement or refund. If they deny it without investigating, that denial is itself a sourcing red flag - and a reason to move to a provider that names its pharmacy and supplies a COA.
Where to get it
Honest take on where to source this peptide. Open the free account first; that's how we get credited even if you skip the code at checkout.
Transparent-pricing telehealth marketplace ยท Katalys
Sesame Care
Fits: You want a real video consult with a US-licensed provider who surfaces the brand-name + insurance pathway honestly alongside cash-pay compounded - not an async rubber-stamp. Composite 34.5/50, the highest of the audited cohort (Tier B verging on A).
Watch: Marketplace model: the experience varies by which provider you book, and 5 of 10 doctor-ethical axes are still pending our sign-up walkthrough. We score what we can verify and flag what we cannot. Read provider reviews before booking.
Step 1 Open a free account at Sesame Care ->Affiliate relationships are disclosed per FTC rules. Editorial take is independent of any commercial relationship; we only recommend what we'd actually use.
Questions readers actually ask
How do I know if my GLP-1 vial was short-filled?
Draw the full contents of the vial into a syringe and read the volume against the markings, then compare it to the labeled volume. A vial labeled 3mL should draw close to 3mL. The other tell is dose count: if a vial that should give you eight doses runs empty after four or five at your correct prescribed dose, the volume was short. Photograph the label, the filled syringe, and the empty vial so you have evidence before you escalate.
What do I do if my compounded vial has less than the labeled volume?
Document it - photos of the label, the filled syringe against its markings, and the empty vial - then report the labeled-versus-measured gap in writing to both the provider and the dispensing pharmacy and request a replacement or refund. Keep the packing slip. If the provider denies the discrepancy without investigating (as one buyer experienced when told she 'must have been mistaken'), treat that as a sourcing red flag and switch to a provider whose 503A pharmacy is named and supplies a certificate of analysis per lot.
How can I verify a compounding pharmacy's product quality before I order?
Ask the provider to name the 503A or 503B compounding pharmacy that actually fills the prescription, and ask for a certificate of analysis (COA) for the lot you will receive - a COA documents potency and purity testing. Providers that will not name the pharmacy or produce a COA are the ones most associated with short-fills and quality complaints. In our framework, a publicly named pharmacy plus a per-lot COA is the product-quality-verification floor, and that axis is weighted 1.5x because it is load-bearing for patient safety.
Is a short-filled GLP-1 vial dangerous or just a rip-off?
It is both a rip-off and a quality-control failure that should worry you. The immediate harm is financial - you paid for medication you did not receive and the vial runs out early. The deeper concern is what a short-fill says about the pharmacy's process: a fill error on volume raises reasonable questions about consistency on potency and sterility too, which are the parts you cannot measure at home. That is why a short-fill is a reason to re-examine where you are sourcing from entirely, not only to ask for a refund.
What does the labeled concentration on a GLP-1 vial mean for my dose?
The concentration (for example 10mg/mL) tells you how much active drug is in each milliliter, which is what lets you convert your prescribed dose in milligrams into a volume to draw in syringe units. If the vial volume is short but the concentration is correct, you get fewer total doses than you paid for. If the concentration itself is off, your per-dose amount is wrong even when the volume looks right - which is exactly why an independent certificate of analysis matters: it verifies the concentration you are dosing against, not just the volume in the vial.
Where to go next
- The full GLP-1 telehealth matrix - all the audited partners side by side
- How we evaluate partners - the 10-axis framework and the public audit log
- Should you get on a GLP-1? - the decision before the provider
- Subscribe to the dispatch
Subscribe to the dispatch
None of this replaces a doctor. Compounded GLP-1s are dispensed under the FDA 503A shortage framework, not FDA-approved. Pricing changes. Talk to a real prescriber before you start, switch, or stop anything.